High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes

Journal of Infectious Diseases

Volumn 176, Issue 1, 1997, Pages 69-77

  Smith, Irene L ^b   Cherrington, Julie M ^b   Jiles, Rhett E ^b   Fuller, Michael D ^b   Freeman, William R ^b   Spector, Stephen A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; DNA POLYMERASE; FOSCARNET; GANCICLOVIR; GANCICLOVIR CYCLIC PHOSPHATE; PHOSPHOTRANSFERASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CROSS RESISTANCE; CYTOMEGALOVIRUS; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; RETINITIS; VIRUS ISOLATION; VIRUS MUTATION;

EID: 0030991256     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514041     Document Type: Article

References (10)

1. Kuppermann BD, Petty JG, Richman DD, Mathews WC, Fullerton SC, Freeman WR. Cross-sectional prevalence of CMV retinitis in AIDS patients: correlation with CD4 counts. Invest Ophthalmol Vis Sci 1992;33:750.
2. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol 1989;107:75-80.
3. Erice A, Chou S, Biron KK, Stanat SC, Balfour HH, Jordan MC. Progressive disease due to ganciclovir-resistant Cytomegalovirus in immunocompromised patients. N Engl J Med 1989;320:289-93.
4. Stanat CS, Reardon JE, Erice A, Jordan MC, Drew WL, Biron KK. Ganciclovir-resistant Cytomegalovirus clinical isolates: mode of resistance to ganciclovir. Antimicrob Agents Chemother 1991;35:2191-7.
5. Jacobsen MA, Drew WL, Feinberg J, et al. Foscarnet therapy for ganciclovir-resistant patients with AIDS. J Infect Dis 1991;163:1348-51.
6. Smith IL, Jiles RE, Spector SA. Reduced Cytomegalovirus susceptibility to foscarnet is found in ganciclovir resistant isolates and foscarnet resistance is conferred by mutations in the CMV polymerase [abstract]. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1995.
7. Sarasini A, Baldanti F, Furione M, et al. Double resistance to ganciclovir and foscarnet of four human Cytomegalovirus strains recovered from AIDS patients. J Med Virol 1995;47:237-44.
8. Baldanti F, Underwood MR, Stanat SC, et al. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double resistant human Cytomegalovirus strains recovered from patients with AIDS. J Virol 1996;70:1390-5.
9. Baldanti F, Silini E, Sarasini A, et al. A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human Cytomegalovirus clinical isolate. J Virol 1995;69:796-800.
10. Gerna G, Baldanti F, Zavattoni M, Sarasini A, Percivalle E, Revello MG. Monitoring of ganciclovir sensitivity of multiple human Cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay. Antiviral Res 1992;19:333-45.